tradingkey.logo

Aflac Inc

AFL
View Detailed Chart

109.130USD

+0.440+0.40%
Close 09/12, 16:00ETQuotes delayed by 15 min
58.36BMarket Cap
23.95P/E TTM

Aflac Inc

109.130

+0.440+0.40%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.40%

5 Days

+2.06%

1 Month

+3.64%

6 Months

+1.75%

Year to Date

+5.50%

1 Year

+0.50%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-12

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
38 / 112
Overall Ranking
115 / 4724
Industry
Insurance

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 15 analysts
Hold
Current Rating
108.750
Target Price
-0.35%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Aflac Incorporated is a provider of supplemental health insurance products. The Company's insurance business is marketed and administered through Aflac Life Insurance Japan Ltd. (ALIJ) in Japan and through American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC) and Aflac Benefit Solutions, Inc. (ABS) in the United States. Its segments include Aflac Japan and Aflac U.S. Aflac Japan is designed to help consumers pay for medical and non-medical costs that are not reimbursed under Japan's national health insurance system. Its insurance products include cancer, medical and income support insurance, nursing care insurance, work leave insurance, whole life, GIFT and WAYS and child endowment. It designs its United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 23.20.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 20.72%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 20.72%.
Overvalued
The company’s latest PE is 24.47, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 378.09M shares, decreasing 2.21% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 50.54M shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Aflac Incorporated is a provider of supplemental health insurance products. The Company's insurance business is marketed and administered through Aflac Life Insurance Japan Ltd. (ALIJ) in Japan and through American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC) and Aflac Benefit Solutions, Inc. (ABS) in the United States. Its segments include Aflac Japan and Aflac U.S. Aflac Japan is designed to help consumers pay for medical and non-medical costs that are not reimbursed under Japan's national health insurance system. Its insurance products include cancer, medical and income support insurance, nursing care insurance, work leave insurance, whole life, GIFT and WAYS and child endowment. It designs its United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage.
Ticker SymbolAFL
CompanyAflac Inc
CEOMr. Daniel P. Amos
Websitehttps://www.aflac.com/
KeyAI